Breaking News
Get 45% Off 0
📅 Plan for Wealth: Don't miss this week's most important financial events
See Economic Calendar

Zacks Investment Research Zacks Investment Research

Zacks Investment Research's Opinion & Analysis.
Featured here: a complete archive of all posts and research produced by Zacks Investment Research, including current material.
Is Archrock (AROC) A Worthy Stock for Value Investors Now? By Zacks Investment Research - Mar 08, 2021

Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are...

2 Top-Ranked Tech Stocks to Buy on the Dip By Zacks Investment Research - Mar 08, 2021

On today’s episode of Full Court Finance at Zacks, we look at the market’s movement and fundamentals over the last several weeks. The episode then explores two highly-ranked stocks that...

ETF Areas to Consider as Senate Passes COVID-19 Relief Bill By Zacks Investment Research - Mar 08, 2021

Wall Street is expected to get a boost from the latest positive development in the stimulus bill. Notably, the Senate approved President Joe Biden’s $1.9-trillion coronavirus relief package,...

Momentum ETFs to Gain From the New Stimulus Optimism By Zacks Investment Research - Mar 08, 2021

The optimism surrounding another tranche of coronavirus-aid package and coronavirus-vaccine development is hinting at a Wall Street rally in March. On Mar 6, Senate approved President Joe...

4 Sector ETFs to Sizzle on Solid February Jobs Data By Zacks Investment Research - Mar 08, 2021

The U.S. economy added 379,000 jobs in February 2021, after an upwardly revised 166,000 rise in January and beating market expectations of a rise of 182,000 thanks to easing business restrictions amid...

ASGN or DT: Which Is the Better Value Stock Right Now? By Zacks Investment Research - Mar 07, 2021

Investors interested in stocks from the Computers - IT Services sector have probably already heard of ASGN Inc (NYSE:ASGN) and Dynatrace (NYSE:DT). But which of these two stocks presents investors...

Rising Loans Aid U.S. Bancorp (USB), Legal Issues Prevail By Zacks Investment Research - Mar 07, 2021

On Mar 5, we issued an updated research report on U.S. Bancorp USB. The company continues to gain from organic and inorganic growth strategies, rising loan and deposit balances, while escalating...

Boise Cascade (BCC) Just Overtook the 50-Day Moving Average By Zacks Investment Research - Mar 07, 2021

After reaching an important support level, Boise Cascade (NYSE:BCC) could be a good stock pick from a technical perspective. BCC surpassed resistance at the 50-day moving average, suggesting a...

Why Is Zimmer (ZBH) Down 1.4% Since Last Earnings Report? By Zacks Investment Research - Mar 06, 2021

A month has gone by since the last earnings report for Zimmer Biomet (ZBH). Shares have lost about 1.4% in that time frame, underperforming the S&P 500.Will the recent negative trend continue...

Is Lockheed (LMT) A Worthy Stock for Value Investors Now? By Zacks Investment Research - Mar 06, 2021 1

Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are...

Why Is Cigna (CI) Up 12.3% Since Last Earnings Report? By Zacks Investment Research - Mar 05, 2021

A month has gone by since the last earnings report for Cigna (CI). Shares have added about 12.3% in that time frame, outperforming the S&P 500.Will the recent positive trend continue leading up to...

Late Rally Saves Week for S&P, Dow By Zacks Investment Research - Mar 05, 2021

The market’s weekly performance ended up looking a lot better than was expected just this afternoon, as stocks snapped their three-day losing streak with a sharp rally on Friday that pulled...

Tidewater (TDW) Reports Q4 Loss, Tops Revenue Estimates By Zacks Investment Research - Mar 05, 2021

Tidewater (NYSE:TDW) came out with a quarterly loss of $0.57 per share versus the Zacks Consensus Estimate of a loss of $0.49. This compares to loss of $0.64 per share a year ago. These figures are...

Continue with Apple
Continue with Google
or
Sign up with Email